These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12481952)

  • 1. Cheap research is likely to be biased.
    White A; Hart A
    Complement Ther Med; 2002 Jun; 10(2):59-60. PubMed ID: 12481952
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary and alternative medicine in outcomes research.
    Riley D; Berman B
    Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498
    [No Abstract]   [Full Text] [Related]  

  • 3. Mega-trials for blockbusters.
    Ioannidis JP
    JAMA; 2013 Jan; 309(3):239-40. PubMed ID: 23321760
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical factors for credibility in clinical trials: Comments on Aickin's "Beyond randomization".
    Walach H
    J Altern Complement Med; 2002 Dec; 8(6):773-5. PubMed ID: 12614530
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost effectiveness of complementary treatments in the United Kingdom: systematic review.
    Canter PH; Coon JT; Ernst E
    BMJ; 2005 Oct; 331(7521):880-1. PubMed ID: 16223821
    [No Abstract]   [Full Text] [Related]  

  • 6. TREAT: tamper-resistant envelope allocation technique for a multisite study.
    Sheeder J; Seale RA; Weber Yorga KD
    J Clin Epidemiol; 2016 Feb; 70():280-3. PubMed ID: 26415578
    [No Abstract]   [Full Text] [Related]  

  • 7. Extending the useful life of clinical trials.
    Cowper PA; Peterson ED
    Am Heart J; 2000 Oct; 140(4):552-3. PubMed ID: 11011326
    [No Abstract]   [Full Text] [Related]  

  • 8. PRESTO (a mammoth trial that could have been prevented), HPS and REMATCH.
    Doehner W; Ponikowski P; Anker SD
    Int J Cardiol; 2002 May; 83(2):99-102. PubMed ID: 12007680
    [No Abstract]   [Full Text] [Related]  

  • 9. The evaluation of different approaches to randomized clinical trials. Report on the 1987 MacArthur Foundation Network I Methodology Workshop.
    Kraemer HC; Pruyn JP
    Arch Gen Psychiatry; 1990 Dec; 47(12):1163-9. PubMed ID: 2147099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health services research clinical trials: issues in the evaluation of economic costs and benefits.
    Manheim LM
    Control Clin Trials; 1998 Apr; 19(2):149-58. PubMed ID: 9551279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.
    Detsky AS
    Stat Med; 1990; 9(1-2):173-84. PubMed ID: 2111932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local IRBs, multicenter trials, and the ethics of internal amendments.
    Jansen LA
    IRB; 2005; 27(4):7-11. PubMed ID: 16220628
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness of screening for clinical trials by research assistants versus senior investigators.
    Miller NL; Markowitz JC; Kocsis JH; Leon AC; Brisco ST; Garno JL
    J Psychiatr Res; 1999; 33(2):81-5. PubMed ID: 10221739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues and complementary therapies: researching intangibles?
    Carter B
    Complement Ther Nurs Midwifery; 2003 Aug; 9(3):133-9. PubMed ID: 12852929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is right and what is wrong about evidence-based medicine?
    Julian DG
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S2-5. PubMed ID: 12950509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine in asthma--safety, effectiveness and costs.
    Brutsche MH
    Swiss Med Wkly; 2002 Jun; 132(25-26):329-31. PubMed ID: 12422288
    [No Abstract]   [Full Text] [Related]  

  • 18. The tactics of large randomized trials.
    Slobogean GP; Sprague S; Bhandari M
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():19-23. PubMed ID: 22810442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point.
    Margolin A
    J Altern Complement Med; 1999 Feb; 5(1):103-4. PubMed ID: 10100036
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical company-sponsored drug trials: what are we to believe?
    Shekelle P
    J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.